Tekla Capital Management LLC Pfizer Inc Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 1,624,476 shares of PFE stock, worth $44.6 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares

1,624,476

Previous 1,775,076 8.48%

Holding current value

$44.6 Million

Previous $72.4 Million 17.73%

% of portfolio

2.36%

Previous 2.78%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $5.44 Million - $6.29 Million	-150,600 Reduced 8.48%	1,624,476 $59.6 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $12.5 Million - $16.3 Million	317,906 Added 21.82%	1,775,076 $72.4 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $13.6 Million - $17.7 Million	325,067 Added 28.71%	1,457,170 $74.7 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $1.85 Million - $2.2 Million	-39,800 Reduced 3.4%	1,132,103 $59.4 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $29.8 Million - $44.2 Million	721,524 Added 160.2%	1,171,903 $69.2 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $9.15 Million - $10.4 Million	-254,880 Reduced 36.14%	450,379 $17.6 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $33.2 Million - $42.2 Million	-990,509 Reduced 58.41%	705,259 $26 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.25 Million - $1.46 Million	39,220 Added 2.37%	1,695,768 $62.2 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $4.93 Million - $5.98 Million	-163,700 Reduced 8.99%	1,656,548 $54.2 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $7.17 Million - $10.2 Million	-265,100 Reduced 12.71%	1,820,248 $59.4 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $953,297 - $1.08 Million	-28,958 Reduced 1.37%	2,085,348 $81.7 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $1.5 Million - $1.94 Million	46,041 Added 2.23%	2,114,306 $76 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $92,449 - $103,800	-2,500 Reduced 0.12%	2,068,265 $89.6 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $20.8 Million - $22.8 Million	553,972 Added 36.52%	2,070,765 $87.9 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $6.26 Million - $7.14 Million	162,700 Added 12.02%	1,516,793 $66.2 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $34.7 Million - $42 Million	-1,005,594 Reduced 42.62%	1,354,093 $59.7 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $10.1 Million - $10.8 Million	307,744 Added 15.0%	2,359,687 $85.6 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $34.4 Million - $39.9 Million	1,076,856 Added 110.44%	2,051,943 $72.8 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $5.49 Million - $5.82 Million	165,000 Added 20.37%	975,087 $35.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	810,087	810,087 $27.2 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Pfizer Inc Transaction History